{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:49:33Z","timestamp":1787701773029,"version":"build-2784847793"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Public Health Service of Amsterdam"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Mycoplasma genitalium, a sexually transmitted bacterium, faces increasing antibiotic resistance, particularly to azithromycin. However, presence of macrolide resistance-associated mutations (MRAMs) does not evidently implicate azithromycin treatment failure. This study aimed to establish an in vitro co-culture system of M. genitalium isolates and perform phenotypic susceptibility testing for different antibiotics, focusing on azithromycin to evaluate genotypic and phenotypic resistance across MRAMs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Urine specimens testing positive for M. genitalium via nucleic acid amplification were co-cultured with Vero cells. Phenotypic susceptibility testing was performed for eight antibiotics. Growth inhibition and MIC of M. genitalium by azithromycin were compared across different MRAMs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>M. genitalium was cultured from 20\/40 (50.0%) positive urine samples, with phenotypic susceptibility tested in a subset. MICs ranged as follows: azithromycin (0.008\u2013&amp;gt;32\u2005mg\/L), levofloxacin (1\u20134\u2005mg\/L), moxifloxacin (&amp;lt;0.25\u20131\u2005mg\/L), sitafloxacin (&amp;lt;0.032\u20130.25\u2005mg\/L), minocycline (&amp;lt;0.25\u20131\u2005mg\/L), doxycycline (&amp;lt;0.125\u20132\u2005mg\/L), spectinomycin (&amp;lt;2.5\u2013&amp;gt;25\u2005mg\/L) and lefamulin (&amp;lt;0.004\u20130.063\u2005mg\/L). Isolates with A2058T demonstrated 24-, 7-, 15- and 12-fold increases in growth inhibition compared with A2058G at azithromycin concentrations of 4, 8, 16 and 32\u2005mg\/L, respectively (P\u200a&amp;lt;\u200a0.01). MRAMs ranked from low to high impact on MIC range were as follows: wildtype (0.008\u20130.016), A2058T (8\u201332), A2059G (\u226532) and A2058G (&amp;gt;32).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study revealed that M. genitalium isolates vary in azithromycin-induced growth inhibition across MRAMs, potentially explaining differences in clinical treatment efficacy. Phenotypic susceptibility testing for other antibiotics demonstrated relatively low MICs. Future studies should incorporate clinical treatment efficacy and symptom severity to optimize treatment for M. genitalium.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkae430","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T19:22:28Z","timestamp":1733858548000},"page":"465-471","source":"Crossref","is-referenced-by-count":5,"title":["Phenotypic antibiotic resistance of <i>Mycoplasma genitalium<\/i> and its variation between different macrolide resistance-associated mutations"],"prefix":"10.1093","volume":"80","author":[{"given":"T A","family":"Doelman","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Amsterdam UMC Location University of Amsterdam , Amsterdam ,","place":["The Netherlands"]},{"name":"Infectious Diseases, Amsterdam Institute for Immunology and Infectious Diseases , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Adriaens","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Amsterdam Institute for Immunology and Infectious Diseases , Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Infectious Diseases, Public Health Service of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B M","family":"Westerhuis","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Public Health Service of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Bruisten","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Amsterdam Institute for Immunology and Infectious Diseases , Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Infectious Diseases, Public Health Service of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C E","family":"Vergunst","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Public Health Service of Amsterdam , Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Dermatology, Noordwest Ziekenhuisgroep location Den Helder , Den Helder ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F M","family":"Bouwman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Public Health Service of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A P","family":"van Dam","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Amsterdam UMC Location University of Amsterdam , Amsterdam ,","place":["The Netherlands"]},{"name":"Infectious Diseases, Amsterdam Institute for Immunology and Infectious Diseases , Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Infectious Diseases, Public Health Service of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"2025020223515083400_dkae430-B1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/0140-6736(93)91411-E","article-title":"Association of Mycoplasma genitalium with acute non-gonococcal urethritis","volume":"342","author":"Horner","year":"1993","journal-title":"Lancet"},{"key":"2025020223515083400_dkae430-B2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/sti.69.4.265","article-title":"Mycoplasma genitalium: a cause of male urethritis?","volume":"69","author":"Jensen","year":"1993","journal-title":"Genitourin Med"},{"key":"2025020223515083400_dkae430-B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2004.00923.x","article-title":"Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases","volume":"18","author":"Jensen","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025020223515083400_dkae430-B4","doi-asserted-by":"publisher","first-page":"476.e1","DOI":"10.1016\/j.ajog.2012.02.036","article-title":"Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service","volume":"206","author":"Bjartling","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2025020223515083400_dkae430-B5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/sti.2008.035477","article-title":"Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics","volume":"85","author":"Gaydos","year":"2009","journal-title":"Sex Transm Infect"},{"key":"2025020223515083400_dkae430-B6","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1017\/S095026882300064X","article-title":"Epidemiology of Mycoplasma genitalium and Trichomonas vaginalis in the primary health care setting in the Netherlands","volume":"151","author":"Yusuf","year":"2023","journal-title":"Epidemiol Infect"},{"key":"2025020223515083400_dkae430-B7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/0956462421999287","article-title":"High prevalence and resistance rates of Mycoplasma genitalium among patients visiting two sexually transmitted infection clinics in the Netherlands","volume":"32","author":"Hetem","year":"2021","journal-title":"Int J STD AIDS"},{"key":"2025020223515083400_dkae430-B8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1128\/MMBR.62.4.1094-1156.1998","article-title":"Molecular biology and pathogenicity of mycoplasmas","volume":"62","author":"Razin","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"key":"2025020223515083400_dkae430-B9","doi-asserted-by":"publisher","first-page":"e066368","DOI":"10.1136\/bmjopen-2022-066368","article-title":"Prevalence of fluoroquinolone resistance-associated mutations in Mycoplasma genitalium among clients of two sexual health centres in the Netherlands: a cross-sectional study","volume":"12","author":"Braam","year":"2022","journal-title":"BMJ Open"},{"key":"2025020223515083400_dkae430-B10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/jdv.17972","article-title":"2021 European guideline on the management of Mycoplasma genitalium infections","volume":"36","author":"Jensen","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025020223515083400_dkae430-B11","doi-asserted-by":"publisher","first-page":"ofaa291","DOI":"10.1093\/ofid\/ofaa291","article-title":"Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance","volume":"7","author":"Doyle","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025020223515083400_dkae430-B12","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1093\/jac\/dkac281","article-title":"Challenges of in vitro propagation and antimicrobial susceptibility testing of Mycoplasma genitalium","volume":"77","author":"Pitt","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2025020223515083400_dkae430-B13","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/cid\/ciad057","article-title":"gyrA mutations in Mycoplasma genitalium and their contribution to moxifloxacin failure: time for the next generation of resistance-guided therapy","volume":"76","author":"Murray","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025020223515083400_dkae430-B14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jiac.2021.11.011","article-title":"Analysis of fluoroquinolone-resistance using MIC determination and homology modelling of ParC of contemporary Mycoplasma genitalium strains","volume":"28","author":"Hamasuna","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2025020223515083400_dkae430-B15","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1128\/AAC.49.12.4993-4998.2005","article-title":"Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5\u2019 nuclease real-time PCR","volume":"49","author":"Hamasuna","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2025020223515083400_dkae430-B16","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1086\/593188","article-title":"Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance","volume":"47","author":"Jensen","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025020223515083400_dkae430-B17","doi-asserted-by":"publisher","first-page":"e0081921","DOI":"10.1128\/JCM.00819-21","article-title":"Azithromycin and doxycycline resistance profiles of U.S. Mycoplasma genitalium strains and their association with treatment outcomes","volume":"59","author":"Wood","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2025020223515083400_dkae430-B18","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/jac\/dkw584","article-title":"High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands","volume":"72","author":"Braam","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2025020223515083400_dkae430-B19","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/jac\/dkv136","article-title":"High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment","volume":"70","author":"Nijhuis","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2025020223515083400_dkae430-B20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/OLQ.0000000000001591","article-title":"Macrolide-resistant Mycoplasma genitalium impairs clinical improvement of male urethritis after empirical treatment","volume":"49","author":"Braam","year":"2022","journal-title":"Sex Transm Dis"},{"key":"2025020223515083400_dkae430-B21","doi-asserted-by":"publisher","first-page":"e624","DOI":"10.1093\/cid\/ciaa293","article-title":"Prevalence of Mycoplasma genitalium infection, antimicrobial resistance mutations, and symptom resolution following treatment of urethritis","volume":"71","author":"Bachmann","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025020223515083400_dkae430-B22","doi-asserted-by":"publisher","first-page":"e0240836","DOI":"10.1371\/journal.pone.0240836","article-title":"Evaluating the prevalence and risk factors for macrolide resistance in Mycoplasma genitalium using a newly developed qPCR assay","volume":"15","author":"Braam","year":"2020","journal-title":"PLoS One"},{"key":"2025020223515083400_dkae430-B23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1128\/JCM.42.2.683-692.2004","article-title":"Use of TaqMan 5\u2019 nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic","volume":"42","author":"Jensen","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2025020223515083400_dkae430-B24","doi-asserted-by":"publisher","first-page":"e0241584","DOI":"10.1371\/journal.pone.0241584","article-title":"Development of lipL32 real-time PCR combined with an internal and extraction control for pathogenic Leptospira detection","volume":"15","author":"Ahmed","year":"2020","journal-title":"PLoS One"},{"key":"2025020223515083400_dkae430-B25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1128\/JCM.02056-06","article-title":"Isolation of Mycoplasma genitalium from first-void urine specimens by coculture with vero cells","volume":"45","author":"Hamasuna","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2025020223515083400_dkae430-B26","doi-asserted-by":"publisher","first-page":"e02380-17","DOI":"10.1128\/AAC.02380-17","article-title":"In vitro activity of lefamulin against sexually transmitted bacterial pathogens","volume":"62","author":"Paukner","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025020223515083400_dkae430-B27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1128\/AAC.38.4.738","article-title":"In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae","volume":"38","author":"Kaku","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"2025020223515083400_dkae430-B28","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1099\/00222615-47-12-1115","article-title":"Comparative susceptibilities of various aids-associated and human urogenital tract mycoplasmas and strains of Mycoplasma Pneumoniae to 10 classes of antimicrobial agent in vitro","volume":"47","author":"Hannan","year":"1998","journal-title":"J Med Microbiol"},{"key":"2025020223515083400_dkae430-B29","doi-asserted-by":"publisher","first-page":"e0198355","DOI":"10.1371\/journal.pone.0198355","article-title":"Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains","volume":"13","author":"Hamasuna","year":"2018","journal-title":"PLoS One"},{"key":"2025020223515083400_dkae430-B30","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1128\/AAC.02411-14","article-title":"In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2025020223515083400_dkae430-B31","doi-asserted-by":"publisher","first-page":"e0162924","DOI":"10.1371\/journal.pone.0162924","article-title":"Antimicrobial susceptibility patterns of recent Cuban Mycoplasma genitalium isolates determined by a modified cell-culture-based method","volume":"11","author":"Mondeja","year":"2016","journal-title":"PLoS One"},{"key":"2025020223515083400_dkae430-B32","author":"NVDV"},{"key":"2025020223515083400_dkae430-B33","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1128\/AAC.45.6.1794-1798.2001","article-title":"Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils","volume":"45","author":"Mandell","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2025020223515083400_dkae430-B34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00044011-199815020-00009","article-title":"Pharmacokinetics of oral azithromycin in serum, urine, polymorphonuclear leucocytes and inflammatory vs non-inflammatory skin blisters in healthy volunteers","volume":"15","author":"Ballow","year":"1998","journal-title":"Clin Drug Investig"},{"key":"2025020223515083400_dkae430-B35","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1128\/AAC.02011-12","article-title":"Blood, tissue, and intracellular concentrations of azithromycin during and after End of therapy","volume":"57","author":"Matzneller","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2025020223515083400_dkae430-B36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"Foulds","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"2025020223515083400_dkae430-B37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/jac\/dkg138","article-title":"Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg","volume":"51","author":"Danesi","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2025020223515083400_dkae430-B38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/jac\/dkn032","article-title":"Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin","volume":"61","author":"Lucchi","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2025020223515083400_dkae430-B39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/COPD.S681","article-title":"Role of macrolide therapy in chronic obstructive pulmonary disease","volume":"3","author":"Martinez","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025020223515083400_dkae430-B40","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1080\/22221751.2020.1775498","article-title":"In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium","volume":"9","author":"Jensen","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2025020223515083400_dkae430-B41","doi-asserted-by":"publisher","first-page":"e0021321","DOI":"10.1128\/JCM.00213-21","article-title":"Overview of changes to the clinical and laboratory standards institute. Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st edition","volume":"59","author":"Humphries","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2025020223515083400_dkae430-B42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/cid\/ciu217","article-title":"Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey","volume":"59","author":"Salado-Rasmussen","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025020223515083400_dkae430-B43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/sextrans-2023-055900","article-title":"Changes in prevalence of Mycoplasma genitalium macrolide and fluoroquinolone resistance: notes from a 13-year retrospective survey in Dalarna County, Sweden","volume":"99","author":"Drud","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2025020223515083400_dkae430-B44","doi-asserted-by":"publisher","first-page":"e35593","DOI":"10.1371\/journal.pone.0035593","article-title":"Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis","volume":"7","author":"Twin","year":"2012","journal-title":"PLoS One"},{"key":"2025020223515083400_dkae430-B45","doi-asserted-by":"publisher","first-page":"e01084-20","DOI":"10.1128\/JCM.01084-20","article-title":"Prevalence of Mycoplasma genitalium and antibiotic resistance-associated mutations in patients at a sexually transmitted infection clinic in Iceland, and comparison of the S-DiaMGTV and aptima Mycoplasma genitalium assays for diagnosis","volume":"58","author":"Hilmarsd\u00f3ttir","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2025020223515083400_dkae430-B46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12879-018-3523-9","article-title":"Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem","volume":"18","author":"Mondeja","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2025020223515083400_dkae430-B47","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1128\/JCM.00370-17","article-title":"High macrolide resistance in Mycoplasma genitalium strains causing infection in Auckland, New Zealand","volume":"55","author":"Basu","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2025020223515083400_dkae430-B48","doi-asserted-by":"publisher","first-page":"2300318","DOI":"10.2807\/1560-7917.ES.2024.29.7.2300318","article-title":"Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022","volume":"29","author":"De Baetselier","year":"2024","journal-title":"Eurosurveill"},{"key":"2025020223515083400_dkae430-B49","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/antibiotics11111492","article-title":"Increases in the macrolide resistance of Mycoplasma genitalium and the emergence of the A2058T mutation in the 23S rRNA gene: clonal spread?","volume":"11","author":"Pi\u00f1eiro","year":"2022","journal-title":"Antibiotics"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/2\/465\/60951377\/dkae430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/2\/465\/60951377\/dkae430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T23:52:05Z","timestamp":1738540325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/2\/465\/7916509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,12,4]]},"published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae430","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,12,4]]}}}